Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells.

Microglial cells and astrocytes are capable of processing and presenting antigens for efficient activation of T cells. However, the antigen-presenting function and role of cerebrovascular endothelial cells (CVEs) in central nervous system inflammatory responses remain controversial. We compared the expression of necessary accessory molecules and the functional antigen-presenting capacity of cloned SJL/J CVEs and primary astrocytes in response to the pro-inflammatory cytokines interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha). Astrocytes and CVEs up-regulated major histocompatibility complex (MHC) class II, and primarily B7-1 as opposed to B7-2, in response to IFN-gamma. TNF-alpha inhibited the IFN-gamma-induced up-regulation of MHC class II on CVEs correlating to a decrease in the mRNA for the class II transactivator (CIITA), whereas CIITA expression in astrocytes was unaffected. Unlike astrocytes, CVEs did not elicit significant MHC class II-restricted T-cell responses. Furthermore, we have found that CVE monolayers are altered following T-cell contact, implicating CVE/T-cell contact in the breakdown of the blood-brain barrier during neuro-inflammatory responses.

[1]  Roland Martin,et al.  The immunopathogenesis of multiple sclerosis. , 2002, Journal of rehabilitation research and development.

[2]  S. Miller,et al.  Direct Activation of Innate and Antigen-Presenting Functions of Microglia following Infection with Theiler's Virus , 2001, Journal of Virology.

[3]  H. Lipton,et al.  High Numbers of Viral RNA Copies in the Central Nervous System of Mice during Persistent Infection with Theiler's Virus , 2001, Journal of Virology.

[4]  H. Lipton,et al.  UDP-galactose transporter is required for Theiler's virus entry into mammalian cells. , 2001, Virology.

[5]  J. Platt,et al.  Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. , 1999, Journal of immunology.

[6]  S. Miller,et al.  Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. , 1998, Journal of immunology.

[7]  S. Zamvil,et al.  Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells , 1998, Journal of Neuroimmunology.

[8]  L. Adorini,et al.  Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. , 1998, Journal of immunology.

[9]  L. Matis,et al.  Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. , 1998, Journal of immunology.

[10]  J. Ting,et al.  Identification of Distinct Regions of 5′ Flanking DNA That Mediate Constitutive, IFN-γ, STAT1, and TGF-β-Regulated Expression of the Class II Transactivator Gene , 1998, The Journal of Immunology.

[11]  N. Rothwell Immune responses in the nervous system , 1997 .

[12]  T. Mak,et al.  Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. , 1997, Immunity.

[13]  B. Mach,et al.  Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA , 1997, The EMBO journal.

[14]  R. Ransohoff,et al.  TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. , 1997, Journal of immunology.

[15]  K. Gordon,et al.  IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. , 1997, Journal of immunology.

[16]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[17]  R. Lechler,et al.  Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells , 1996, The Journal of experimental medicine.

[18]  K. Okumura,et al.  CD86 (B70/B7-2) on endothelial cells co-stimulates allogeneic CD4+ T cells. , 1995, International immunology.

[19]  M. Croft,et al.  Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. , 1995, Journal of immunology.

[20]  A. Strosberg,et al.  Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin‐1 , 1995, European journal of immunology.

[21]  S. Miller,et al.  Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases , 1995, Immunological reviews.

[22]  R. Flavell,et al.  Class II transactivator regulates the expression of multiple genes involved in antigen presentation , 1995, The Journal of experimental medicine.

[23]  P. Linsley,et al.  CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. , 1995, Journal of immunology.

[24]  Y. Lee,et al.  Characterization of astrocyte nuclear proteins involved in IFN-gamma- and TNF-alpha-mediated class II MHC gene expression. , 1994, Journal of immunology.

[25]  R. Flavell,et al.  Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes , 1994, The Journal of experimental medicine.

[26]  B. Mach,et al.  Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. , 1994, Science.

[27]  J. Bluestone,et al.  The B7 and CD28 receptor families. , 1994, Immunology today.

[28]  P. Linsley,et al.  Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. , 1994, Journal of immunology.

[29]  D. Montgomery,et al.  Astrocytes: Form, Functions, and Roles in Disease , 1994, Veterinary pathology.

[30]  B. Mach,et al.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) , 1993, Cell.

[31]  Roger D. Smith,et al.  Correlation between susceptibility to demyelination and interferon-γ induction of major histocompatibility complex class II antigens on murine cerebrovascular endothelial cells , 1993, Journal of Neuroimmunology.

[32]  Y. Ron,et al.  In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. , 1993, Journal of immunology.

[33]  M. Hart,et al.  Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes. , 1993, Journal of immunology.

[34]  M. Eddleston,et al.  Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.

[35]  P. Linsley,et al.  Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7. , 1993, Cellular immunology.

[36]  B. Fleischer,et al.  Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens. , 1993, Journal of immunology.

[37]  S. Miller,et al.  Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein , 1992, Journal of Neuroimmunology.

[38]  P. Linsley,et al.  Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. , 1992, Journal of immunology.

[39]  P. Marrack,et al.  Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Cross,et al.  Anti—tumor necrosis factor therapy abrogates autoimmune demyelination , 1991, Annals of neurology.

[41]  Y. Shimamoto,et al.  Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats , 1991, Journal of Neuroimmunology.

[42]  Klaus Rajewsky,et al.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.

[43]  E. Benveniste,et al.  Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains , 1991, The Journal of experimental medicine.

[44]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[45]  C. Jacob,et al.  Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell. , 1991, Journal of immunology.

[46]  W. Hickey,et al.  T‐lymphocyte entry into the central nervous system , 1991, Journal of neuroscience research.

[47]  D. Willenborg,et al.  Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation , 1990, Journal of the Neurological Sciences.

[48]  V. ter meulen,et al.  Antigen-specific damage to brain vascular endothelial cells mediated by encephalitogenic and nonencephalitogenic CD4+ T cell lines in vitro. , 1990, Journal of immunology.

[49]  R. Clark,et al.  An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis , 1990, The Journal of experimental medicine.

[50]  R. McCarron,et al.  The inhibitory effect of tumor necrosis factor and interleukin-1 on Ia induction by interferon-γ on endothelial cells from murine central nervous system microvessels , 1990, Journal of Neuroimmunology.

[51]  B. Engelhardt,et al.  Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro , 1990, The Journal of cell biology.

[52]  D. McFarlin,et al.  Chronic relapsing experimental allergic encephalomyelitis. Cytotoxicity effected by a class II restricted T cell line specific for an encephalitogenic epitope. , 1989, Journal of immunology.

[53]  D. Willoughby,et al.  Presentation of myelin basic protein by normal guinea-pig brain endothelial cells and its relevance to experimental allergic encephalomyelitis. , 1989, Immunology.

[54]  G. Pryce,et al.  Antigen presentation in brain: brain endothelial cells are poor stimulators of T-cell proliferation. , 1989, Immunology.

[55]  G. Pryce,et al.  Induction of Ia molecules on brain endothelium is related to susceptibility to experimental allergic encephalomyelitis , 1989, Journal of Neuroimmunology.

[56]  G. Wong,et al.  Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. , 1988, Journal of immunology.

[57]  D. Mason,et al.  Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system , 1987, The Journal of experimental medicine.

[58]  H. Lassmann,et al.  Cellular immune reactivity within the CNS , 1986, Trends in Neurosciences.

[59]  R. McCarron,et al.  Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. , 1986, Journal of immunology.

[60]  H. Wekerle,et al.  Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes , 1986, Nature.

[61]  R. McCarron,et al.  Presentation of myelin basic protein by murine cerebral vascular endothelial cells. , 1985, Journal of immunology.

[62]  B. Arnason Relevance of experimental allergic encephalomyelitis to multiple sclerosis. , 1983, Neurologic clinics.

[63]  R. Hughes,et al.  Immunology of the Nervous System , 1983 .

[64]  J. Longmire,et al.  Isolation of a B-cell-specific promoter for the human class II transactivator , 1997, Immunogenetics.

[65]  J. Banchereau,et al.  CD40-CD40 ligand: a multifunctional receptor-ligand pair. , 1996, Advances in immunology.

[66]  M. Yacoub,et al.  Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes. , 1996, Immunology.

[67]  P. Knopf,et al.  Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. , 1992, Immunology today.

[68]  Y. Shimamoto,et al.  Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. , 1991, Journal of neuroimmunology.

[69]  G. Pryce,et al.  Kinetics of MHC gene expression and mRNA synthesis in brain endothelium. , 1988, Immunology.